---

Prescription Guidelines

Mr. Battle: To ask the Secretary of State for Health how many medicines are currently contained in the prescription guidelines; and if the guidelines include brand names. [29317]

Mr. Malone: I refer the hon. Member to the reply I gave my hon. Friend the Member for Macclesfield (Mr. Winterton) on 18 December 1995, Official Report, column 946 and to the reply I gave to my hon. Friend the Member for Croydon, North-East (Mr. Congdon) on 19 December 1995, Official Report, column 1154.

Doctors

Ms Harman: To ask the Secretary of State for Health how many of those who completed their training as doctors in each of the last 10 years were (a) men and (b) women. [29323]

Mr. Malone: I refer the hon. Member to the reply I gave her on 19 March, Official Report, column 190.

Embryos

Mr. Alton: To ask the Secretary of State for Health what proposals he has to instruct the Human Fertilisation and Embryology Authority to contract donors of sperm or eggs whose embryos will be kept past the five-year limit. [29338]

Mr. Horam: Most embryos currently in store were created from gametes from couples being treated together. In a small number of cases, donor gametes were used. The Human Fertilisation and Embryology Authority has issued guidance on the steps to be taken to alert couples and, where appropriate, donors to the arrangements available for extending the storage period. The authority has also had a series of meetings with centres where it has stressed the importance of making all reasonable effort to contact those whose embryos are nearing the end of their storage period.

Committees (Membership)

Mr. Martyn Jones: To ask the Secretary of State for Health (1) if he will list the present members of (a) the Committee on the Medical Aspects of Food Policy, (b) the Committee on Mutagenicity of Chemicals in Food and (c) the Committee on Toxicity of Chemicals in Foods, together with their current employers; [29285]

(2) which present members of (a) the Committee on the Medical Aspects of Food Policy, (b) the Committee on Mutagenicity of Chemicals in Food and (c) the Committee on Toxicity of Chemicals in Food, are in receipt of grants from private companies. [29286]

Mr. Horam: Current membership of the Committee on Medical Aspects of Food Policy is as follows:

16 May 1996 : Column: 535

Chairman
Sir K. Calman: Chief Medical Officer
Members
Professor P. Aggett: Head of Department of Nutrition, Diet and Health, Biotechnology and Biological Research Council Institute of Food Research, Norwich
Professor K. Alberti ¹ : Professor of Medicine, University of Newcastle upon Tyne
Dr S. Bingham: Senior Scientist, Medical Research Council Dunn Clinical Nutrition Centre, Cambridge
Dr. H. Campbell ¹ : Chief Medical Officer, Department of Health and Social Security Northern Ireland
Professor F. Cockburn: Samson Gemmell Professor of Child Health, University of Glasgow
Dr. H. Denner (until July 1995) ¹ : Chief Scientist (Food), Ministry of Agriculture, Fisheries and Food
Mr. B. Dickinson (From August 1995) ¹ : Ministry of Agriculture, Fisheries and Food
Professor J. Grimley Evans: Division of Geriatric Medicine, Nuffield Department of Clinical Medicine, University of Oxford
Ms A . Foster: Director, Scottish Consumer Council
Dr. G. Fowler: Clinical Reader in General Practice, Department of Public Health and Primary Care, University of Oxford
Dr. D. Hine ¹ : Chief Medical Office, Scottish Office
Professor A. A. Jackson: Professor of Human Nutrition, University of Southampton
Professor W. P. T. James: Director, Rowett Research Institute, Aberdeen
Dr. M. Kemp ¹ : Medical Research Council
Dr. R. Kendell ¹ : Chief Medical Officer, Welsh Office
Professor M. Marmot: Professor of Epidemiology and Public Health, University College Medical School, London
Dr. D. Richardson: Nestle UK Limited
Ms L. Stockley ¹ : Health Education Authority ¹ Ex officio.

Current membership of the Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Enviornment is as follows:

Members
Professor J. M. Parry (Chair): University College of Swansea
Professor J. Ashby: Zeneca
Professor R. L. Carter: The Royal Marsden NHS Trust
Dr. J. Cole: Medical Research Council, University of Sussex
Dr. C. Cooper: The Institute of Cancer Research, Haddow Laboratories
Professor D. S. Davies: Royal Postgraduate Medical School, Hammersmith Hospital
Professor H. J. Evans: Medical Research Council Human Genetics Unit, Western General Hospital
Professor R. F. Newbold: The University of West London
Dr. D. J. Tweats: Glaxo Research and Development Ltd.
Dr. S. Venitt: The Institute of Cancer Research, Haddow Laboratories.

Current membership of the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment is as follows:

Members
Professor H. F. Woods (Chair): Royal Hallamshire Hospital
Professor P. Aggett: Biotechnology and Biological Sciences Research Council, Norwich
Dr. P. N. Bennett: University of Bath, Wolfson Centre

16 May 1996 : Column: 536

Dr. N. A. Brown: Medical Research Council Experimental Embryology and Teratology Unit, St. George's Hospital Medical School
Dr. J. K. Chipman: The University of Birmingham
Professor A. D. Dayan: Department of Health Toxicology Laboratory
Professor G. G. Gibson: University of Surrey
Professor G. M. Hawksworth: University of Aberdeen
Dr. M. Joffe: St. Mary's Hospital Medical School
Dr. I. Kimber: Zeneca
Dr. D. Prentice: Self employed
Dr. A. G. Renwick: University of Southampton
Dr. A. G. Smith: University of Leicester
Dr. A. Thomas: Plymouth General Hospital
Dr. M. J. Tucker: Retired

Relevant grants for research from private companies are declared by members in the appropriate register of commercial interests. A copy of these are available in the Library.

General Practitioners

Ms Harman: To ask the Secretary of State for Health how many of whose who completed their training as GPs in each of the last 10 years were (a) men and (b) women.[29324]

Mr. Malone: The information is not available centrally.

Ms Harman: To ask the Secretary of State for Health how many of those in general practice in each of the last 10 years were (a) men and (b) women. [29322]

Mr. Malone: This information is contained in "General Medical Services Statistics for England and Wales", copies of which are available in the Library.

NHS Trusts (Insurance Premiums)

Mr. Milburn: To ask the Secretary of State for Health what are the costs to trusts of paying insurance premiums each year. [29667]

Mr. Horam: Information on national health service trust insurance premium costs is not available centrally.

Supervision Registers

Mr. Milburn: To ask the Secretary of State for Health how many patients are currently on supervision registers. [29671]

Mr. Bowis: The latest complete set of information indicates that 3,498 patients were reported to be on supervision registers at 31 December 1995.

Property Sales

Mr. Milburn: To ask the Secretary of State for Health, pursuant to his answer of 21 March, Official Report, column 321, (1) what estimate he has made of the annual proceeds from the sale of properties in each of the next 10 years; [29714]

(2) if his estimate of proceeds from the sale of surplus or potentially surplus properties has been assumed in published public expenditure survey accounts. [29715]

16 May 1996 : Column: 537

Mr. Horam: The estimated annual proceeds from the sale of non-national health service trust properties over the next four years is shown in the table, together with an aggregate estimate of sales after 2000. The figures are based on the best estimate of estates advisors to the NHS executive. The estimates are based on current open market values and are liable to change as a result of fluctuations in property market values. Actual proceeds may be subject to considerable variation since many properties scheduled for sale are currently in operational use and the estimates are based on provisional disposal dates.

Estimates of the proceeds from the sale of surplus non-national health service trust properties have been taken into account as capital receipts in the Government's expenditure plans, published as Cm 3212 in March.

Year	Estimated annual proceeds £ million
1996-97	237
1997-98	220
1998-99	213
1999-00	223
Post 2000	311
Total	1,204

Regional Health Authorities (Financial Reserves)

Mr. Milburn: To ask the Secretary of State for Health what financial reserves have been held by regions for each of the last four years. [29670]

Mr. Horam: Donation reserve by regional health authorities in England are shown in the tables.

£ Thousands

	1991-92	1992-93	1993-94
Northern RHA	48	40	93
Yorkshire RHA	224	222	48
Trent RHA	101	69	48
East Anglia RHA	65	53	758
North West Thames RHA	0	36	737
North East Thames RHA	0	0	0
South East Thames RHA	0	0	0
South West Thames RHA	117	11	0
Wessex RHA	0	0	0
Oxford RHA	0	0	0
South Western RHA	0	0	0
West Midlands RHA	0	0	0
Mersey RHA	0	0	0
North Western RHA	10	8	7

	1994-95
	£000s
Northern and Yorkshire RHA	1,905
Trent RHA	0
Anglia and Oxford RHA	1,636
North East Thames RHA	0
South West Thames RHA	0
South and West RHA	0
West Midlands RHA	0
North West RHA	4

Source:

The annual accounts of regional and district health authorities and the special health authorities of the London postgraduate teaching hospitals.

16 May 1996 : Column: 538

---